PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15668340-6	2005	Dipyridamole but not aspirin attenuated nuclear translocation of NF-kappaB and blocked the synthesis of MCP-1 at the transcriptional level.	Dipyridamole	0-12	C-C motif chemokine ligand 2	Homo sapiens	104-109	
22942727-2	2012	Preclinical studies indicate that treatment with acetylsalicylic acid + extended-release dipyridamole (ASA + ER-DP) has anti-inflammatory and thereby neuroprotective effects by inhibition of monocyte chemotactic protein-1 (MCP-1) expression.	Dipyridamole	89-101	C-C motif chemokine ligand 2	Homo sapiens	191-221	
22942727-2	2012	Preclinical studies indicate that treatment with acetylsalicylic acid + extended-release dipyridamole (ASA + ER-DP) has anti-inflammatory and thereby neuroprotective effects by inhibition of monocyte chemotactic protein-1 (MCP-1) expression.	Dipyridamole	89-101	C-C motif chemokine ligand 2	Homo sapiens	223-228	
15668340-10	2005	Dipyridamole also blocked MCP-1 and MMP-9 generated by lipopolysaccharide-treated monocytes, indicating that at least part of its inhibitory action is unrelated to its antiplatelet properties.	Dipyridamole	0-12	C-C motif chemokine ligand 2	Homo sapiens	26-31	
34912231-10	2021	Besides, MCP-1 levels were significantly decreased in HR-DP and HR-CB groups compared to the HR-C group (p-value <= 0.05).	Dipyridamole	57-59	C-C motif chemokine ligand 2	Homo sapiens	9-14